BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 233 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,527,717 | +298.4% | 780,751 | +296.2% | 0.01% | +250.0% |
Q2 2023 | $1,387,436 | +311.3% | 197,079 | +387.3% | 0.00% | -20.0% |
Q1 2023 | $337,303 | -95.7% | 40,444 | -94.1% | 0.01% | -96.5% |
Q4 2022 | $7,826,295 | +86.7% | 681,733 | +104.8% | 0.14% | +78.8% |
Q3 2022 | $4,193,000 | +564.5% | 332,814 | +458.4% | 0.08% | +370.6% |
Q2 2022 | $631,000 | -78.7% | 59,598 | -67.4% | 0.02% | -78.5% |
Q1 2022 | $2,969,000 | +402.4% | 182,567 | +343.9% | 0.08% | +364.7% |
Q3 2021 | $591,000 | +167.4% | 41,131 | +194.7% | 0.02% | +112.5% |
Q2 2021 | $221,000 | -29.4% | 13,958 | -91.1% | 0.01% | -88.4% |
Q1 2020 | $313,000 | -12.3% | 156,507 | +51.4% | 0.07% | +200.0% |
Q4 2019 | $357,000 | – | 103,350 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |